Search
for
Sort by
Research 421–450 of 506
- A4. Hair loss – surgical and pharmacological treatment
- Association of 5α-Reductase Inhibitors With Dementia, Depression, and Suicide
- Outcome of Dutasteride 0.5mg in Androgenic Alopecia
- Caffeic acid N-[3,5-bis(trifluoromethyl)phenyl] amide as a non-steroidal inhibitor for steroid 5α-reductase type 1 using a human keratinocyte cell-based assay and molecular dynamics
- The challenging role of antiandrogens in the management of polycystic ovary syndrome
- LB792 Minoxidil and dutasteride drug tattooing for male Androgenetic Alopecia
- Two Cases of Paradoxical Nonscarring Alopecia after Mesotherapy with Dutasteride
- Faculty Opinions recommendation of Post-finasteride syndrome: a surmountable challenge for clinicians.
- A preliminary result of adipose derived stem cell treatment for female pattern hair loss
- Dutasteride/finasteride
- Post-finasteride syndrome: our current knowledge
- Dutasteride/finasteride
- Tu1491 – Use of Androgen Lowering Medications Finasteride and Dutasteride Do Not Substantially Alter Risk of Incident Hcvrelated Hepatcellular Carcinoma in Men
- Change in Hair Growth-related Gene Expression Profile in Human Isolated Hair Follicles Induced by 5-alpha Reductase Inhibitors, Dutasteride and Finasteride, in the Presence of Testosterone
- Adverse events with finasteride or dutasteride: FAERS
- Assessing finasteride-associated sexual dysfunction using the FAERS database
- Post-Finasteride Syndrome: An Underestimated Phenomenon
- Duration of finasteride and dutasteride treatment linked to long-term erectile dysfunction
- No increased risk of CV events with dutasteride vs finasteride
- Dutasteride, finasteride: no increased risk of ED
- Review: Dutasteride, fesoterodine, and finasteride are beneficial for lower urinary tract symptoms in older patients
- Finasteride and dutasteride may reduce melanoma risk
- PD16-01 NEW INSIGHT OF PSA REDUCTION DURING FINASTERIDE THERAPY
- Evaluation of the efficacy and safety of topical and oral treatments on hormonal and androgenetic alopecia
- Sponsored Lecture 3 : Updates on 5 alpha-rers(5ARIs) for the treatment of male pattern hair loss(MPHL)
- Faculty Opinions recommendation of Dutasteride improves male pattern hair loss in a randomized study in identical twins.
- Retrospective Pharmacotherapeutic Evaluation of Dutasteride not Approved by US FDA for Androgenetic Alopecia in Korea
- Pharmacology of anabolic steroids
- Erectile Dysfunction in Young Men—A Review of the Prevalence and Risk Factors
- Genome-wide association study identifies a new locus JMJD1C at 10q21 that may influence serum androgen levels in men